About Pacific GeneTech
Pacific GeneTech is a company based in Hong Kong (China) founded in 2009.. Pacific GeneTech has raised $10 million across 1 funding round from investors including Arkansas.gov, Simmons Foods and WHIST. Pacific GeneTech offers products and services including Aegis Vaccine Platform, Hercules Adjuvant System, and Salmonella Vaccine. Pacific GeneTech operates in a competitive market with competitors including Biological E, Insmed, Affinivax, Merck Animal Health and Altimmune, among others.
- Headquarter Hong Kong, China
-
Sectors
HealthcareAgriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pacific Genetech Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10 M (USD)
in 1 rounds
-
Latest Funding Round
$10 M (USD), Series A
Aug 24, 2022
-
Investors
Arkansas.gov
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pacific GeneTech
Pacific GeneTech offers a comprehensive portfolio of products and services, including Aegis Vaccine Platform, Hercules Adjuvant System, and Salmonella Vaccine. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables broad-spectrum protection for vaccines against pathogens
Supports administration of inactivated vaccines for enhanced efficacy
Targets Salmonella in poultry and livestock for disease prevention
Funding Insights of Pacific GeneTech
Pacific GeneTech has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $10.0M
-
First Round
First Round
(24 Aug 2022)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Series A - Pacific GeneTech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pacific GeneTech
Pacific GeneTech has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Arkansas.gov, Simmons Foods and WHIST. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Simmons Foods is engaged in poultry and pet food production.
|
Founded Year | Domain | Location | |
|
Access to government programs and development services is provided.
|
Founded Year | Domain | Location | |
|
Women's health and empowerment services are provided in South Tyneside.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pacific GeneTech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pacific GeneTech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pacific Genetech Comparisons
Competitors of Pacific GeneTech
Pacific GeneTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Insmed, Affinivax, Merck Animal Health and Altimmune, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule inhibitors for rare lung diseases
|
|
| domain | founded_year | HQ Location |
Technology-based conjugate vaccines against infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Vaccine technology is developed and supplied for livestock animals.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for treating multiple infectious diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pacific Genetech
Frequently Asked Questions about Pacific GeneTech
When was Pacific GeneTech founded?
Pacific GeneTech was founded in 2009 and raised its 1st funding round 13 years after it was founded.
Where is Pacific GeneTech located?
Pacific GeneTech is headquartered in Hong Kong, China.
Who is the current CEO of Pacific GeneTech?
Tim Collard is the current CEO of Pacific GeneTech.
Is Pacific GeneTech a funded company?
Pacific GeneTech is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series A of $10M, raised on Aug 24, 2022.
What does Pacific GeneTech do?
Pacific GeneTech was founded in 2009 in Hong Kong, China, within the biotechnology sector. Vaccines targeting viral, bacterial, and parasitic diseases in animals and humans are developed using microbial vectors via the Aegis Vaccine Platform for gene insertion. Operations focus on gene delivery systems, with a pipeline that includes PGT Hercules Adjuvant, a modified chitosan applied to multiple disease indications.
Who are the top competitors of Pacific GeneTech?
Pacific GeneTech's top competitors include Biological E, Insmed and Vaxart.
What products or services does Pacific GeneTech offer?
Pacific GeneTech offers Aegis Vaccine Platform, Hercules Adjuvant System, and Salmonella Vaccine.
Who are Pacific GeneTech's investors?
Pacific GeneTech has 4 investors. Key investors include Arkansas.gov, Simmons Foods, WHIST, and PT Medion Ardhika Bhakti.